Retour

GeneDx Reports First Quarter 2024 Financial Results and Business Highlights

Stocks Earnings Releases and Operating Results

GeneDx Holdings Corp. (Nasdaq: WGS) today reported its financial results for the first quarter of 2024.

GlobeNewswire Inc. • 29/04/2024 à 22:05:00
GeneDx Holdings Corp. Class A Common Stock
Address: 333 LUDLOW STREET
Postal Code: 06902
City: STAMFORD
State: CT
Phone Number: 617 780 8742
Website: https://www.genedx.com
Status: Active
Company Info

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. It has two segments GeneDx, which derives maximum revenue and Legacy Sema4 diagnostics.

List Date2021-07-23
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001818331
Composite figiBBG00XDHY5P9
Share Class figiBBG00XDHY5R7
Market Cap542,630,470 USD
SIC Code8000
SIC DescriptionSERVICES-HEALTH SERVICES
Total Employees1000
Share Class Shares Outstanding26150000
Weighted Shares Outstanding26150866
Round Lot100
Updated date2024-05-12
Stats
Last 5 days
15-05
14-05
13-05
10-05
9-05
Last
22.229
21.22
23.65
21.18
20.82
Variance
4.12%
-10.27%
11.98%
1.73%
6.36%
Open
21.35
23.65
21.119
20.82
19.575
Highest
22.41
24.51
23.72
21.355
20.82
Lowest
22.41
24.509
23.712
21.301
20.82
History
PeriodVarhighestlowest
1 week
13.56%
20.82
20.82
1 month
110.68%
13.1
10.51
3 month
399.53%
5.25
4.3716
6 month
1609.92%
1.48
1.16
1 year
215.3%
7.05
1.16
3 year
103.51%
12.0582
1.16
5 year
103.51%
12.0582
1.16
10 year
103.51%
12.0582
1.16
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-09 2023-08-08 2023-11-03 UNPUB
Assets 545,295,000 476,390,000 417,285,000 UNPUB
Current Assets 272,348,000 213,277,000 171,813,000 UNPUB
Current Liabilities 119,032,000 84,368,000 68,366,000 UNPUB
Equity 328,469,000 296,113,000 254,258,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 328,469,000 296,113,000 254,258,000 UNPUB
Liabilities 216,826,000 180,277,000 163,027,000 UNPUB
Liabilities And Equity 545,295,000 476,390,000 417,285,000 UNPUB
Noncurrent Assets 272,947,000 263,113,000 245,472,000 UNPUB
Noncurrent Liabilities 97,794,000 95,909,000 94,661,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-09 2023-08-08 2023-11-03 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 76,636,000 -57,384,000 -69,268,000 UNPUB
Net Cash Flow, Continuing 76,636,000 -57,384,000 -69,268,000 UNPUB
Net Cash Flow From Financing Activities 132,658,000 7,388,000 -911,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 132,658,000 7,388,000 -911,000 UNPUB
Net Cash Flow From Investing Activities -462,000 -11,271,000 -27,129,000 UNPUB
Net Cash Flow From Investing Activities, Continuing -462,000 -11,271,000 -27,129,000 UNPUB
Net Cash Flow From Operating Activities -55,560,000 -53,501,000 -41,228,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -55,560,000 -53,501,000 -41,228,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-09 2023-08-08 2023-11-03 UNPUB
Comprehensive Income/Loss -60,989,000 -46,719,000 -42,286,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -60,989,000 -46,719,000 -42,286,000 UNPUB
Other Comprehensive Income/Loss -60,989,000 -46,719,000 0 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-09 2023-08-08 2023-11-03 UNPUB
Basic Earnings Per Share -3 -2 -2 UNPUB
Benefits Costs and Expenses 104,275,000 95,621,000 95,761,000 UNPUB
Cost Of Revenue 27,903,000 29,949,000 28,044,000 UNPUB
Costs And Expenses 104,275,000 95,621,000 95,761,000 UNPUB
Diluted Earnings Per Share -3 -2 -2 UNPUB
Gross Profit 15,236,000 18,757,000 25,259,000 UNPUB
Income/Loss From Continuing Operations After Tax -60,989,000 -46,719,000 -42,286,000 UNPUB
Income/Loss From Continuing Operations Before Tax -61,136,000 -46,915,000 -42,458,000 UNPUB
Income Tax Expense/Benefit -147,000 -196,000 -172,000 UNPUB
Interest Expense, Operating 767,000 626,000 UNPUB UNPUB
Net Income/Loss -60,989,000 -46,719,000 -42,286,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -60,989,000 -46,719,000 -42,286,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -60,989,000 -46,719,000 -42,286,000 UNPUB
Operating Expenses 75,600,000 70,379,000 68,226,000 UNPUB
Operating Income/Loss -60,364,000 -51,622,000 -42,967,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 43,139,000 48,706,000 53,303,000 UNPUB
Calendar
15 May 2024 (Time UTC) Actual Previous Consensus
★
16:00
United States
MAR
100500000000.000
62900000000.000
★
16:00
United States
MAR
71500000000.000
89300000000.000
★
16:00
United States
MAR
102100000000.000
42000000000
★
16:00
United States
MAR
42200000000.000
87400000000.000
★★
15:20
United States
★
15:00
United States
MAR
★
15:00
United States
MAR
★★
12:00
United States
★
12:00
United States
★
11:00
United States
APR
0.300
0.400
★
10:30
United States
MAY 17
108000.000
-353000.000
★
10:30
United States
MAY 10
-45000.000
560000.000
770000.000
★
10:30
United States
MAY 10
-235000.000
915000.000
880000.000
★
10:30
United States
21000.000
275000.000
★
10:30
United States
MAY 10
307000.000
307000.000
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:WGS240419P00015000 OPASPS Put American 100 15 BATO 2024-04-19
O:WGS240419P00012500 OPASPS Put American 100 12.5 BATO 2024-04-19
O:WGS240419P00010000 OPASPS Put American 100 10 BATO 2024-04-19
O:WGS240419C00015000 OCASPS Call American 100 15 BATO 2024-04-19
O:WGS240419C00012500 OCASPS Call American 100 12.5 BATO 2024-04-19
O:WGS240419C00010000 OCASPS Call American 100 10 BATO 2024-04-19
O:WGS240419P00007500 OPASPS Put American 100 7.5 BATO 2024-04-19
O:WGS240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:WGS240419P00002500 OPASPS Put American 100 2.5 BATO 2024-04-19
O:WGS240419C00007500 OCASPS Call American 100 7.5 BATO 2024-04-19
O:WGS240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:WGS240419C00002500 OCASPS Call American 100 2.5 BATO 2024-04-19
O:WGS240315P00015000 OPASPS Put American 100 15 BATO 2024-03-15
O:WGS240315P00012500 OPASPS Put American 100 12.5 BATO 2024-03-15
O:WGS240315P00010000 OPASPS Put American 100 10 BATO 2024-03-15
O:WGS240315P00007500 OPASPS Put American 100 7.5 BATO 2024-03-15
O:WGS240315P00005000 OPASPS Put American 100 5 BATO 2024-03-15
O:WGS240315P00002500 OPASPS Put American 100 2.5 BATO 2024-03-15
O:WGS240315C00015000 OCASPS Call American 100 15 BATO 2024-03-15
O:WGS240315C00012500 OCASPS Call American 100 12.5 BATO 2024-03-15
O:WGS240315C00010000 OCASPS Call American 100 10 BATO 2024-03-15
O:WGS240315C00007500 OCASPS Call American 100 7.5 BATO 2024-03-15
O:WGS240315C00005000 OCASPS Call American 100 5 BATO 2024-03-15
O:WGS240315C00002500 OCASPS Call American 100 2.5 BATO 2024-03-15
O:WGS240216P00007500 OPASPS Put American 100 7.5 BATO 2024-02-16
O:WGS240216P00005000 OPASPS Put American 100 5 BATO 2024-02-16
O:WGS240216P00002500 OPASPS Put American 100 2.5 BATO 2024-02-16
O:WGS240216C00007500 OCASPS Call American 100 7.5 BATO 2024-02-16
O:WGS240216C00005000 OCASPS Call American 100 5 BATO 2024-02-16
O:WGS240216C00002500 OCASPS Call American 100 2.5 BATO 2024-02-16
O:WGS240119P00015000 OPASPS Put American 100 15 BATO 2024-01-19
O:WGS240119P00012500 OPASPS Put American 100 12.5 BATO 2024-01-19
O:WGS240119P00010000 OPASPS Put American 100 10 BATO 2024-01-19
O:WGS240119P00007500 OPASPS Put American 100 7.5 BATO 2024-01-19
O:WGS240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:WGS240119P00002500 OPASPS Put American 100 2.5 BATO 2024-01-19
O:WGS240119C00015000 OCASPS Call American 100 15 BATO 2024-01-19
O:WGS240119C00012500 OCASPS Call American 100 12.5 BATO 2024-01-19
O:WGS240119C00010000 OCASPS Call American 100 10 BATO 2024-01-19
O:WGS240119C00007500 OCASPS Call American 100 7.5 BATO 2024-01-19
O:WGS240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:WGS240119C00002500 OCASPS Call American 100 2.5 BATO 2024-01-19
O:WGS1240119P00017500 OPASPN Put American 4 17.5 BATO 2024-01-19
O:WGS1240119P00015000 OPASPN Put American 4 15 BATO 2024-01-19
O:WGS1240119P00012500 OPASPN Put American 4 12.5 BATO 2024-01-19
O:WGS1240119P00010000 OPASPN Put American 4 10 BATO 2024-01-19
O:WGS1240119P00007500 OPASPN Put American 4 7.5 BATO 2024-01-19
O:WGS1240119P00005500 OPASPN Put American 4 5.5 BATO 2024-01-19
O:WGS1240119P00005000 OPASPN Put American 4 5 BATO 2024-01-19
O:WGS1240119P00004500 OPASPN Put American 4 4.5 BATO 2024-01-19
O:WGS1240119P00004000 OPASPN Put American 4 4 BATO 2024-01-19
O:WGS1240119P00003500 OPASPN Put American 4 3.5 BATO 2024-01-19
O:WGS1240119P00003000 OPASPN Put American 4 3 BATO 2024-01-19
O:WGS1240119P00002500 OPASPN Put American 4 2.5 BATO 2024-01-19
O:WGS1240119P00002000 OPASPN Put American 4 2 BATO 2024-01-19
O:WGS1240119P00001500 OPASPN Put American 4 1.5 BATO 2024-01-19
O:WGS1240119P00001000 OPASPN Put American 4 1 BATO 2024-01-19
O:WGS1240119P00000500 OPASPN Put American 4 0.5 BATO 2024-01-19
O:WGS1240119C00017500 OCASPN Call American 4 17.5 BATO 2024-01-19
O:WGS1240119C00015000 OCASPN Call American 4 15 BATO 2024-01-19
O:WGS1240119C00012500 OCASPN Call American 4 12.5 BATO 2024-01-19
O:WGS1240119C00010000 OCASPN Call American 4 10 BATO 2024-01-19
O:WGS1240119C00007500 OCASPN Call American 4 7.5 BATO 2024-01-19
O:WGS1240119C00005500 OCASPN Call American 4 5.5 BATO 2024-01-19
O:WGS1240119C00005000 OCASPN Call American 4 5 BATO 2024-01-19
O:WGS1240119C00004500 OCASPN Call American 4 4.5 BATO 2024-01-19
O:WGS1240119C00004000 OCASPN Call American 4 4 BATO 2024-01-19
O:WGS1240119C00003500 OCASPN Call American 4 3.5 BATO 2024-01-19
O:WGS1240119C00003000 OCASPN Call American 4 3 BATO 2024-01-19
O:WGS1240119C00002500 OCASPN Call American 4 2.5 BATO 2024-01-19
O:WGS1240119C00002000 OCASPN Call American 4 2 BATO 2024-01-19
O:WGS1240119C00001500 OCASPN Call American 4 1.5 BATO 2024-01-19
O:WGS1240119C00001000 OCASPN Call American 4 1 BATO 2024-01-19
O:WGS1240119C00000500 OCASPN Call American 4 0.5 BATO 2024-01-19
O:WGS231215P00015000 OPASPS Put American 100 15 BATO 2023-12-15
O:WGS231215P00012500 OPASPS Put American 100 12.5 BATO 2023-12-15
O:WGS231215P00010000 OPASPS Put American 100 10 BATO 2023-12-15
O:WGS231215P00007500 OPASPS Put American 100 7.5 BATO 2023-12-15
O:WGS231215P00005000 OPASPS Put American 100 5 BATO 2023-12-15
O:WGS231215P00002500 OPASPS Put American 100 2.5 BATO 2023-12-15
O:WGS231215C00015000 OCASPS Call American 100 15 BATO 2023-12-15
O:WGS231215C00012500 OCASPS Call American 100 12.5 BATO 2023-12-15
O:WGS231215C00010000 OCASPS Call American 100 10 BATO 2023-12-15
O:WGS231215C00007500 OCASPS Call American 100 7.5 BATO 2023-12-15
O:WGS231215C00005000 OCASPS Call American 100 5 BATO 2023-12-15
O:WGS231215C00002500 OCASPS Call American 100 2.5 BATO 2023-12-15
O:WGS1231215P00007500 OPASPN Put American 4 7.5 BATO 2023-12-15
O:WGS1231215P00005000 OPASPN Put American 4 5 BATO 2023-12-15
O:WGS1231215P00002500 OPASPN Put American 4 2.5 BATO 2023-12-15
O:WGS1231215C00007500 OCASPN Call American 4 7.5 BATO 2023-12-15
O:WGS1231215C00005000 OCASPN Call American 4 5 BATO 2023-12-15
O:WGS1231215C00002500 OCASPN Call American 4 2.5 BATO 2023-12-15
O:WGS231117P00010000 OPASPS Put American 100 10 BATO 2023-11-17
O:WGS231117P00007500 OPASPS Put American 100 7.5 BATO 2023-11-17
O:WGS231117P00005000 OPASPS Put American 100 5 BATO 2023-11-17
O:WGS231117P00002500 OPASPS Put American 100 2.5 BATO 2023-11-17
O:WGS231117C00010000 OCASPS Call American 100 10 BATO 2023-11-17
O:WGS231117C00007500 OCASPS Call American 100 7.5 BATO 2023-11-17
O:WGS231117C00005000 OCASPS Call American 100 5 BATO 2023-11-17
O:WGS231117C00002500 OCASPS Call American 100 2.5 BATO 2023-11-17
O:WGS231020P00010000 OPASPS Put American 100 10 BATO 2023-10-20
O:WGS231020P00007500 OPASPS Put American 100 7.5 BATO 2023-10-20
O:WGS231020P00005000 OPASPS Put American 100 5 BATO 2023-10-20
O:WGS231020P00002500 OPASPS Put American 100 2.5 BATO 2023-10-20
O:WGS231020C00010000 OCASPS Call American 100 10 BATO 2023-10-20
O:WGS231020C00007500 OCASPS Call American 100 7.5 BATO 2023-10-20
O:WGS231020C00005000 OCASPS Call American 100 5 BATO 2023-10-20
O:WGS231020C00002500 OCASPS Call American 100 2.5 BATO 2023-10-20
O:WGS230915P00015000 OPASPS Put American 100 15 BATO 2023-09-15
O:WGS230915P00012500 OPASPS Put American 100 12.5 BATO 2023-09-15
O:WGS230915P00010000 OPASPS Put American 100 10 BATO 2023-09-15
O:WGS230915P00007500 OPASPS Put American 100 7.5 BATO 2023-09-15
O:WGS230915P00005000 OPASPS Put American 100 5 BATO 2023-09-15
O:WGS230915P00002500 OPASPS Put American 100 2.5 BATO 2023-09-15
O:WGS230915C00015000 OCASPS Call American 100 15 BATO 2023-09-15
O:WGS230915C00012500 OCASPS Call American 100 12.5 BATO 2023-09-15
O:WGS230915C00010000 OCASPS Call American 100 10 BATO 2023-09-15
O:WGS230915C00007500 OCASPS Call American 100 7.5 BATO 2023-09-15
O:WGS230915C00005000 OCASPS Call American 100 5 BATO 2023-09-15
O:WGS230915C00002500 OCASPS Call American 100 2.5 BATO 2023-09-15
O:WGS1230915P00007500 OPASPN Put American 4 7.5 BATO 2023-09-15
O:WGS1230915P00005000 OPASPN Put American 4 5 BATO 2023-09-15
O:WGS1230915P00002500 OPASPN Put American 4 2.5 BATO 2023-09-15
O:WGS1230915C00007500 OCASPN Call American 4 7.5 BATO 2023-09-15
O:WGS1230915C00005000 OCASPN Call American 4 5 BATO 2023-09-15
O:WGS1230915C00002500 OCASPN Call American 4 2.5 BATO 2023-09-15
O:WGS230818P00012500 OPASPS Put American 100 12.5 BATO 2023-08-18
O:WGS230818P00010000 OPASPS Put American 100 10 BATO 2023-08-18
O:WGS230818P00007500 OPASPS Put American 100 7.5 BATO 2023-08-18
O:WGS230818P00005000 OPASPS Put American 100 5 BATO 2023-08-18
O:WGS230818P00002500 OPASPS Put American 100 2.5 BATO 2023-08-18
O:WGS230818C00012500 OCASPS Call American 100 12.5 BATO 2023-08-18
O:WGS230818C00010000 OCASPS Call American 100 10 BATO 2023-08-18
O:WGS230818C00007500 OCASPS Call American 100 7.5 BATO 2023-08-18
O:WGS230818C00005000 OCASPS Call American 100 5 BATO 2023-08-18
O:WGS230818C00002500 OCASPS Call American 100 2.5 BATO 2023-08-18
News Stream
Stocks Earnings Releases and Operating Results
GeneDx Reports First Quarter 2024 Financial Results and Business Highlights
GeneDx Holdings Corp. (Nasdaq: WGS) today reported its financial results for the first quarter of 2024.
GlobeNewswire Inc. • 2w ago
Management Partnerships
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicine The Company will also participate in a World Orphan Drug Congress panel presentation highlighting the role of genomic sequencing in advancing precision medicine
GlobeNewswire Inc. • 3w ago
Calendar Calendar of Events
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024
Management will host a conference call on Monday, April 29, 2024 to discuss first quarter 2024 financial and operating results at 4:30 p.m. Eastern Time.
GlobeNewswire Inc. • 1mo ago
News News
Here's Why GENEDX HOLDINGS (WGS) Could be Great Choice for a Bottom Fisher
GENEDX HOLDINGS (WGS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Zacks Investment Research • 1mo ago
Calendar Calendar of Events
GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics
STAMFORD, Conn., March 14, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced its scientific contributions at the 2024 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting. Across one platform presentation, an industry symposium and six poster presentations, including one selected as a “Rapid Fire Poster Session,” an invitation-only presentation of the top 20 ACMG posters, GeneDx continues to demonstrate its industry leadership in shaping the future landscape of genomics.
GlobeNewswire Inc. • 2mo ago
Calendar Calendar of Events
GeneDx to Participate in 44th Annual Cowen Health Care Conference
GeneDx (Nasdaq: WGS) today announced that company management will participate in the Cowen Healthcare Conference from March 4-6 in Boston, MA.
GlobeNewswire Inc. • 2mo ago
Stocks Earnings Releases and Operating Results
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
GeneDx Holdings Corp. (Nasdaq: WGS) reported its financial results for the fourth quarter and full year of 2023.
GlobeNewswire Inc. • 2mo ago
Calendar Calendar of Events
GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 
GeneDx management will host a conference call at 4:30 p.m. Eastern Time on February 20, 2024 to discuss 2023 results and share full year 2024 guidance.
GlobeNewswire Inc. • 3mo ago
Stocks Stock Market News
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
STAMFORD, Conn., Jan. 24, 2024 (GLOBE NEWSWIRE) -- GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, today announced that, effective as of January 23, 2024, the compensation committee of GeneDx’s board of directors granted newly hired employees 106,030 restricted stock units (“RSUs”) as inducements material to each employee entering into employment with GeneDx. The RSUs were granted under GeneDx’s 2023 Equity Inducement Plan and in accordance with Nasdaq Listing Rule 5635(c)(4).
GlobeNewswire Inc. • 3mo ago
News Pre-Release Comments
GeneDx Announces Preliminary 2023 Financial Results
Expects to exceed revised 2023 revenue guidance with fourth quarter 2023 revenue from continuing operations of more than $57M.
GlobeNewswire Inc. • 4mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT